Drawing for CARIS CHROMOSEQ

USPTO serial 99153728

CARIS CHROMOSEQ

Reviewed by CopyMark Law Group

Status 748
Filing date
Status date
Registration date
—
Examiner
VAN DEN ABEELEN, DEREK C
Law office
TMO LAW OFFICE 126

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CARIS CHROMOSEQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anne Fleeson

Anne Fleeson Womble Bond Dickinson (US) LLPOne West Fourth StreetWinston-Salem, NC 27101United States

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, whole genome and whole transcriptome sequencing assays for biomarker detection and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignanciesACTIVE—
044Medical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, providing whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignanciesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 2, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 2, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 24, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 23, 2026IUAFUSE AMENDMENT FILED—
Jul 23, 2026EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 23, 2026EX1GSOU EXTENSION 1 GRANTED—
Jul 23, 2026EXT1SOU EXTENSION 1 FILED—
Jul 23, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 30, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 5, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 5, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 29, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 3, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 2, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 5, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jan 5, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Oct 7, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 7, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 7, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 16, 2025DOCKASSIGNED TO EXAMINER—
Sep 2, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 24, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 24, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance